We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts

By HospiMedica International staff writers
Posted on 26 Feb 2024

Almost half of the women aged 40 and above possess dense breast tissue, which increases their susceptibility to breast cancer. More...

The challenge in detecting cancer in these women arises because both dense tissue and cancer appear white on mammograms, leading to a 50% miss rate for cancers in this group. Dense breasts are found in over 40% of women, with a higher prevalence in Black, Asian, and Jewish populations, thus elevating their cancer risk due to genetic factors. Now, an artificial intelligence (AI) technology based on a shape recognition algorithm that can “see through” dense breast tissue offers hope for millions of women whose dense breast tissue masks cancer on mammograms.

DeepLook Medical (New Haven, CT, USA) has pioneered the first AI technology platform designed to visualize suspicious masses in women with dense breasts. This software named DL Precise integrates smoothly with existing imaging systems, enhancing workflow efficiency with simple features like one-click measurement, segmentation, and visualization. DL Precise leverages the company’s unique shape-recognition software to precisely define tumor shapes, which is crucial for accurate diagnosis.

DL Precise is compatible with various imaging techniques such as mammography, ultrasound, CT, and MRI. It features a single-click deterministic algorithm for precise lesion segmentation, thereby boosting workflow productivity. This software, which has received FDA clearance, has recently been introduced into the commercial market through strategic alliances with key channel partners, including Barco (Kortrijk, Belgium). DeepLook is also incorporating additional AI advancements to further improve the effectiveness and scope of its patented technology.

"Our innovative AI technology is a game-changer in the field, offering a streamlined solution for early detection across multiple imaging modalities," said Marissa Fayer, CEO of DeepLook Medical.

“This technology addresses a significant unmet need in medical imaging, enabling rapid and accurate lesion segmentation, measurement, and visualization” says Dirk Feyants, Executive Vice President of Diagnostic Imaging at Barco. “Combined with our displays’ excellent image quality, this tool offers a new layer of confidence to breast radiologists. We are proud to lead the way with DeepLook Medical in offering breast radiologists the essential tools they require to enhance their patients' well-being."

Related Links:
DeepLook Medical
Barco 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.